Screening for prostate cancer in long-term care

Holly M. Holmes, James Goodwin

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Prostate cancer is a common disease and is the second leading cause of cancer-related death in men. However, many older men with prostate cancer will die from comorbid illness rather than cancer. Survival from prostate cancer with available treatment options, including surgery, radiation, androgen suppression, and watchful waiting, is mediated by age, tumor grade, and comorbid illness. Due to the long natural history of prostate cancer and the presence of competing comorbidities, the majority of elderly men with newly diagnosed prostate cancer will not benefit from curative therapy. Even more relevant to the long-term care population is the further lack of benefit from diagnosing early-stage prostate cancer in men with advanced age, multiple comorbidities, and a high prevalence of dementia. Thus, in the longterm care population, a rational approach to the detection of prost ate cancer is to evaluate suspected symptomatic or metastatic disease exclusively.

Original languageEnglish (US)
Pages (from-to)22-28
Number of pages7
JournalAnnals of Long-Term Care
Volume17
Issue number11
StatePublished - Nov 2009
Externally publishedYes

Fingerprint

Long-Term Care
Prostatic Neoplasms
Comorbidity
Neoplasms
Watchful Waiting
Population
Androgens
Dementia
Radiation
Survival
Therapeutics

ASJC Scopus subject areas

  • Geriatrics and Gerontology
  • Gerontology

Cite this

Screening for prostate cancer in long-term care. / Holmes, Holly M.; Goodwin, James.

In: Annals of Long-Term Care, Vol. 17, No. 11, 11.2009, p. 22-28.

Research output: Contribution to journalArticle

Holmes, Holly M. ; Goodwin, James. / Screening for prostate cancer in long-term care. In: Annals of Long-Term Care. 2009 ; Vol. 17, No. 11. pp. 22-28.
@article{70b35f8fae8949e1b2ba1f6f8fa0cc8e,
title = "Screening for prostate cancer in long-term care",
abstract = "Prostate cancer is a common disease and is the second leading cause of cancer-related death in men. However, many older men with prostate cancer will die from comorbid illness rather than cancer. Survival from prostate cancer with available treatment options, including surgery, radiation, androgen suppression, and watchful waiting, is mediated by age, tumor grade, and comorbid illness. Due to the long natural history of prostate cancer and the presence of competing comorbidities, the majority of elderly men with newly diagnosed prostate cancer will not benefit from curative therapy. Even more relevant to the long-term care population is the further lack of benefit from diagnosing early-stage prostate cancer in men with advanced age, multiple comorbidities, and a high prevalence of dementia. Thus, in the longterm care population, a rational approach to the detection of prost ate cancer is to evaluate suspected symptomatic or metastatic disease exclusively.",
author = "Holmes, {Holly M.} and James Goodwin",
year = "2009",
month = "11",
language = "English (US)",
volume = "17",
pages = "22--28",
journal = "Annals of Long-Term Care",
issn = "1524-7929",
publisher = "HMP Communications LLP",
number = "11",

}

TY - JOUR

T1 - Screening for prostate cancer in long-term care

AU - Holmes, Holly M.

AU - Goodwin, James

PY - 2009/11

Y1 - 2009/11

N2 - Prostate cancer is a common disease and is the second leading cause of cancer-related death in men. However, many older men with prostate cancer will die from comorbid illness rather than cancer. Survival from prostate cancer with available treatment options, including surgery, radiation, androgen suppression, and watchful waiting, is mediated by age, tumor grade, and comorbid illness. Due to the long natural history of prostate cancer and the presence of competing comorbidities, the majority of elderly men with newly diagnosed prostate cancer will not benefit from curative therapy. Even more relevant to the long-term care population is the further lack of benefit from diagnosing early-stage prostate cancer in men with advanced age, multiple comorbidities, and a high prevalence of dementia. Thus, in the longterm care population, a rational approach to the detection of prost ate cancer is to evaluate suspected symptomatic or metastatic disease exclusively.

AB - Prostate cancer is a common disease and is the second leading cause of cancer-related death in men. However, many older men with prostate cancer will die from comorbid illness rather than cancer. Survival from prostate cancer with available treatment options, including surgery, radiation, androgen suppression, and watchful waiting, is mediated by age, tumor grade, and comorbid illness. Due to the long natural history of prostate cancer and the presence of competing comorbidities, the majority of elderly men with newly diagnosed prostate cancer will not benefit from curative therapy. Even more relevant to the long-term care population is the further lack of benefit from diagnosing early-stage prostate cancer in men with advanced age, multiple comorbidities, and a high prevalence of dementia. Thus, in the longterm care population, a rational approach to the detection of prost ate cancer is to evaluate suspected symptomatic or metastatic disease exclusively.

UR - http://www.scopus.com/inward/record.url?scp=73149114373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73149114373&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 22

EP - 28

JO - Annals of Long-Term Care

JF - Annals of Long-Term Care

SN - 1524-7929

IS - 11

ER -